vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and MDU RESOURCES GROUP INC (MDU). Click either name above to swap in a different company.

MDU RESOURCES GROUP INC is the larger business by last-quarter revenue ($522.6M vs $487.7M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). MDU RESOURCES GROUP INC runs the higher net margin — 14.6% vs -10.1%, a 24.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -1.6%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (17.0% CAGR vs -5.7%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

MDU Resources Group, Inc. is a U.S.-based corporation supplying products and services to regulated energy delivery and utilities related construction materials and services businesses. It is headquartered in Bismarck, North Dakota, and operates in 48 states.

CLOV vs MDU — Head-to-Head

Bigger by revenue
MDU
MDU
1.1× larger
MDU
$522.6M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+46.3% gap
CLOV
44.7%
-1.6%
MDU
Higher net margin
MDU
MDU
24.7% more per $
MDU
14.6%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
17.0%
-5.7%
MDU

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
MDU
MDU
Revenue
$487.7M
$522.6M
Net Profit
$-49.3M
$76.3M
Gross Margin
Operating Margin
-10.1%
20.5%
Net Margin
-10.1%
14.6%
Revenue YoY
44.7%
-1.6%
Net Profit YoY
-123.2%
38.4%
EPS (diluted)
$-0.10
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
MDU
MDU
Q1 26
$487.7M
Q4 25
$487.7M
$522.6M
Q3 25
$496.6M
$313.6M
Q2 25
$477.6M
$348.7M
Q1 25
$462.3M
$678.0M
Q4 24
$337.0M
$531.0M
Q3 24
$331.0M
$290.7M
Q2 24
$356.3M
$343.1M
Net Profit
CLOV
CLOV
MDU
MDU
Q1 26
$-49.3M
Q4 25
$-49.3M
$76.3M
Q3 25
$-24.4M
$18.3M
Q2 25
$-10.6M
$13.8M
Q1 25
$-1.3M
$82.0M
Q4 24
$-22.1M
$55.2M
Q3 24
$-9.2M
$64.6M
Q2 24
$7.4M
$60.4M
Gross Margin
CLOV
CLOV
MDU
MDU
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
MDU
MDU
Q1 26
-10.1%
Q4 25
-10.1%
20.5%
Q3 25
-4.9%
12.7%
Q2 25
-2.2%
8.7%
Q1 25
-0.3%
16.6%
Q4 24
-6.4%
17.8%
Q3 24
-2.7%
12.0%
Q2 24
2.0%
11.5%
Net Margin
CLOV
CLOV
MDU
MDU
Q1 26
-10.1%
Q4 25
-10.1%
14.6%
Q3 25
-4.9%
5.8%
Q2 25
-2.2%
4.0%
Q1 25
-0.3%
12.1%
Q4 24
-6.6%
10.4%
Q3 24
-2.8%
22.2%
Q2 24
2.1%
17.6%
EPS (diluted)
CLOV
CLOV
MDU
MDU
Q1 26
$-0.10
Q4 25
$0.37
Q3 25
$0.09
Q2 25
$0.07
Q1 25
$0.40
Q4 24
$0.26
Q3 24
$0.32
Q2 24
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
MDU
MDU
Cash + ST InvestmentsLiquidity on hand
$95.3M
$28.2M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$308.7M
$2.8B
Total Assets
$541.0M
$7.6B
Debt / EquityLower = less leverage
0.97×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
MDU
MDU
Q1 26
$95.3M
Q4 25
$78.3M
$28.2M
Q3 25
$75.9M
Q2 25
$58.8M
Q1 25
$59.5M
Q4 24
$194.5M
$66.9M
Q3 24
$288.0M
$88.3M
Q2 24
$254.8M
$78.8M
Total Debt
CLOV
CLOV
MDU
MDU
Q1 26
Q4 25
$2.7B
Q3 25
$2.4B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.3B
Stockholders' Equity
CLOV
CLOV
MDU
MDU
Q1 26
$308.7M
Q4 25
$308.7M
$2.8B
Q3 25
$340.9M
$2.7B
Q2 25
$344.2M
$2.7B
Q1 25
$336.1M
$2.7B
Q4 24
$341.1M
$2.7B
Q3 24
$342.2M
$3.1B
Q2 24
$324.9M
$3.0B
Total Assets
CLOV
CLOV
MDU
MDU
Q1 26
$541.0M
Q4 25
$541.0M
$7.6B
Q3 25
$559.7M
$7.2B
Q2 25
$575.0M
$6.9B
Q1 25
$583.7M
$7.0B
Q4 24
$580.7M
$7.0B
Q3 24
$653.0M
$8.2B
Q2 24
$674.2M
$8.0B
Debt / Equity
CLOV
CLOV
MDU
MDU
Q1 26
Q4 25
0.97×
Q3 25
0.86×
Q2 25
0.80×
Q1 25
0.80×
Q4 24
0.85×
Q3 24
0.76×
Q2 24
0.75×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
MDU
MDU
Operating Cash FlowLast quarter
$0
$80.6M
Free Cash FlowOCF − Capex
$-336.0M
FCF MarginFCF / Revenue
-64.3%
Capex IntensityCapex / Revenue
79.7%
Cash ConversionOCF / Net Profit
1.06×
TTM Free Cash FlowTrailing 4 quarters
$-297.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
MDU
MDU
Q1 26
$0
Q4 25
$-66.9M
$80.6M
Q3 25
$12.1M
$57.9M
Q2 25
$5.4M
$117.4M
Q1 25
$-16.3M
$217.5M
Q4 24
$34.8M
$60.5M
Q3 24
$50.0M
$140.2M
Q2 24
$44.8M
$136.5M
Free Cash Flow
CLOV
CLOV
MDU
MDU
Q1 26
Q4 25
$-69.0M
$-336.0M
Q3 25
$11.4M
$-121.9M
Q2 25
$4.8M
$36.5M
Q1 25
$-16.5M
$124.4M
Q4 24
$33.3M
$-95.8M
Q3 24
$49.6M
$673.0K
Q2 24
$44.4M
$26.5M
FCF Margin
CLOV
CLOV
MDU
MDU
Q1 26
Q4 25
-14.1%
-64.3%
Q3 25
2.3%
-38.9%
Q2 25
1.0%
10.5%
Q1 25
-3.6%
18.4%
Q4 24
9.9%
-18.0%
Q3 24
15.0%
0.2%
Q2 24
12.5%
7.7%
Capex Intensity
CLOV
CLOV
MDU
MDU
Q1 26
Q4 25
0.4%
79.7%
Q3 25
0.1%
57.3%
Q2 25
0.1%
23.2%
Q1 25
0.0%
13.7%
Q4 24
0.5%
29.4%
Q3 24
0.1%
48.0%
Q2 24
0.1%
32.0%
Cash Conversion
CLOV
CLOV
MDU
MDU
Q1 26
Q4 25
1.06×
Q3 25
3.16×
Q2 25
8.52×
Q1 25
2.65×
Q4 24
1.10×
Q3 24
2.17×
Q2 24
6.04×
2.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

MDU
MDU

Natural Gas Distribution$382.8M73%
Commercial Utility Sales$42.7M8%
Residential Utility Sales$33.7M6%
Pipelineand Midstream$31.1M6%
Natural Gas Transportation$17.2M3%
Industrial Utility Sales$10.1M2%
Natural Gas Storage$6.4M1%
Other Utility Sales$1.9M0%

Related Comparisons